• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4603663)   Today's Articles (4915)   Subscriber (49370)
For: Raghunadharao D, Koralewski P, Serwatowski P, Gruszfeld A, Lakshmaiah K, Szczesna A, Savin M, Yen K, Bhatnagar A, Green M. P-560 A randomized phase II study of plvanex and docetaxel comparedto docetaxell monotherapy In patients with previously treated advanced NSCLC. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)81053-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Number Cited by Other Article(s)
1
Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline. J Thorac Oncol 2006. [DOI: 10.1097/01243894-200611000-00021] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
2
Noble J, Ellis P, Mackay J, Evans W. Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline. J Thorac Oncol 2006. [DOI: 10.1016/s1556-0864(15)31641-5] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA